Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity

The burgeoning advances in high-throughput technologies have posed a great challenge to the identification of novel biomarkers for diagnosing, by contemporary models and methods, through bioinformatics-driven analysis. Diagnostic performance metrics such as the partial area under the <inline-form...

Full description

Bibliographic Details
Main Authors: Manuel Franco, Juana-María Vivo
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Mathematics
Subjects:
Online Access:https://www.mdpi.com/2227-7390/9/21/2826
_version_ 1827678114580267008
author Manuel Franco
Juana-María Vivo
author_facet Manuel Franco
Juana-María Vivo
author_sort Manuel Franco
collection DOAJ
description The burgeoning advances in high-throughput technologies have posed a great challenge to the identification of novel biomarkers for diagnosing, by contemporary models and methods, through bioinformatics-driven analysis. Diagnostic performance metrics such as the partial area under the <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula>) indexes exhibit limitations to analysing genomic data. Among other issues, the inability to differentiate between biomarkers whose <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curves cross each other with the same <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula> value, the inappropriate expression of non-concave <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curves, and the lack of a convenient interpretation, restrict their use in practice. Here, we have proposed the fitted partial area index (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>F</mi><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula>), which is computable through an algorithm valid for any <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curve shape, as an alternative performance summary for the evaluation of highly sensitive biomarkers. The proposed approach is based on fitter upper and lower bounds of the <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula> in a high-sensitivity region. Through variance estimates, simulations, and case studies for diagnosing leukaemia, and ovarian and colon cancers, we have proven the usefulness of the proposed metric in terms of restoring the interpretation and improving diagnostic accuracy. It is robust and feasible even when the <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curve shows hooks, and solves performance ties between competitive biomarkers.
first_indexed 2024-03-10T05:57:05Z
format Article
id doaj.art-ac7ba9ebfd6949f59103c075332c5fa3
institution Directory Open Access Journal
issn 2227-7390
language English
last_indexed 2024-03-10T05:57:05Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Mathematics
spelling doaj.art-ac7ba9ebfd6949f59103c075332c5fa32023-11-22T21:19:24ZengMDPI AGMathematics2227-73902021-11-01921282610.3390/math9212826Evaluating the Performances of Biomarkers over a Restricted Domain of High SensitivityManuel Franco0Juana-María Vivo1Department of Statistics and Operations Research, University of Murcia, CEIR Campus Mare Nostrum, 30100 Murcia, SpainDepartment of Statistics and Operations Research, University of Murcia, CEIR Campus Mare Nostrum, 30100 Murcia, SpainThe burgeoning advances in high-throughput technologies have posed a great challenge to the identification of novel biomarkers for diagnosing, by contemporary models and methods, through bioinformatics-driven analysis. Diagnostic performance metrics such as the partial area under the <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula>) indexes exhibit limitations to analysing genomic data. Among other issues, the inability to differentiate between biomarkers whose <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curves cross each other with the same <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula> value, the inappropriate expression of non-concave <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curves, and the lack of a convenient interpretation, restrict their use in practice. Here, we have proposed the fitted partial area index (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>F</mi><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula>), which is computable through an algorithm valid for any <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curve shape, as an alternative performance summary for the evaluation of highly sensitive biomarkers. The proposed approach is based on fitter upper and lower bounds of the <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>p</mi><mi>A</mi><mi>U</mi><mi>C</mi></mrow></semantics></math></inline-formula> in a high-sensitivity region. Through variance estimates, simulations, and case studies for diagnosing leukaemia, and ovarian and colon cancers, we have proven the usefulness of the proposed metric in terms of restoring the interpretation and improving diagnostic accuracy. It is robust and feasible even when the <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>R</mi><mi>O</mi><mi>C</mi></mrow></semantics></math></inline-formula> curve shows hooks, and solves performance ties between competitive biomarkers.https://www.mdpi.com/2227-7390/9/21/2826<i>ROC</i> partial areascaled partial area indexhigh sensitivitynegative diagnostic likelihood ratiovariance of <i>FpAUC</i>biomarker performance
spellingShingle Manuel Franco
Juana-María Vivo
Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity
Mathematics
<i>ROC</i> partial area
scaled partial area index
high sensitivity
negative diagnostic likelihood ratio
variance of <i>FpAUC</i>
biomarker performance
title Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity
title_full Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity
title_fullStr Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity
title_full_unstemmed Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity
title_short Evaluating the Performances of Biomarkers over a Restricted Domain of High Sensitivity
title_sort evaluating the performances of biomarkers over a restricted domain of high sensitivity
topic <i>ROC</i> partial area
scaled partial area index
high sensitivity
negative diagnostic likelihood ratio
variance of <i>FpAUC</i>
biomarker performance
url https://www.mdpi.com/2227-7390/9/21/2826
work_keys_str_mv AT manuelfranco evaluatingtheperformancesofbiomarkersoverarestricteddomainofhighsensitivity
AT juanamariavivo evaluatingtheperformancesofbiomarkersoverarestricteddomainofhighsensitivity